Press Releases

U3O8 Corp. Announces a Clear Path Forward for the Laguna Salada Uranium-Vanadium Deposit

U3O8 Corp is pleased to outline how the offer of a C$1 million line of credit by the Company’s founder and director, Dr. Keith Barron, in addition to funds recently raised by the Company, will be used to undertake proof-of-concept work on its Laguna Salada uranium-vanadium deposit in Argentina. The funds allow the Company to do specific test work that, if successful, is likely to significantly improve the economics of Laguna Salada by lowering operating and capital costs from those determined in the positive preliminary economic assessment (“PEA”) undertaken in 2014.

U3O8 Corp. Announces Closing of Private Placement & Commitment by Shareholder to Fund the Company to Achieve Key Milestones

U3O8 Corp reports that the Company raised gross proceeds of C$517,000 in a private placement that closed yesterday. Meanwhile, Dr. Keith Barron, founder, director and shareholder of U3O8 Corp., has offered to provide a C$1.0 million unsecured operating line of credit to enable U3O8 Corp. to generate proof of concept uranium and vanadium products from the Laguna Salada Deposit.

U3O8 Corp. Highlights Planned Production Profile for Vanadium from the Laguna Salada Deposit Based on a PEA

highlights the production schedule from the Preliminary Economic Assessment (“PEA”) on its Laguna Salada Deposit, in which almost twice as much vanadium would be produced as uranium. “Vanadium prices have risen strongly in response to a supply shortfall that has been developing in the vanadium market,” said Richard Spencer, President & CEO of U3O8 Corp.  “The trigger for the recent sharp price increase was a change in policy in China that resulted in restricted access to vanadium slag and higher local production costs, coming on the back of increasing vanadium consumption, notably from the steel and battery industries.

U3O8 Corp.’s Consolidation Common Shares Start Trading Today; Director Exercises Out-of-the-Money Warrants

Toronto, Ontario – September 11th, 2017 – U3O8 Corp. (TSX: UWE), (OTCQB: UWEFF) (“U3O8 Corp.” or the “Company”) reports that its consolidated common shares will start trading at the open of the TSX and OTCQB markets on Monday September 11th, and that one of the Company’s directors has exercised out-of-the-money warrants to contribute working capital to the Corporation.

U3O8 Corp. Provides an Update on Activities: August, 2017

Toronto, Ontario – August 03, 2017 – U3O8 Corp. (TSX: UWE), (OTCQB: UWEFF) (“U3O8 Corp.” or the “Company”) is pleased to provide an update on activities since its Annual and Special Meeting (“ASM”) held on June 22, 2017, that includes: The closing of the Existing Shareholder Prospectus Exemption (“ESPE”) financing announced on June 27, 2017; Next steps in the stock consolidation that was approved by shareholders at the Company’s recent ASM; Update on metallurgical test work that has been concluded in Australia; and A note on the recent surge in vanadium prices.

U3O8 Corp. Announces Results of Shareholder Meeting and Warrant Cancellation

Toronto, Ontario – June 23, 2017 – U3O8 Corp. (TSX: UWE), (OTCQB: UWEFF) (“U3O8 Corp.” or the “Company”) reports that all matters brought before its shareholders were approved at the Annual & Special Meeting (“ASM”) held yesterday in Toronto, Ontario. A total of 121,790,106 of the Corporation’s common shares were voted, representing 35% of its issued and outstanding stock. In addition, 19.3 million warrants expired and 2.85 million warrants were exercised for gross proceeds of $99,750, which together reduce the number of outstanding warrants by approximately 18%.

U3O8 Corp. Reports Progress on Capital Restructuring / Director Warrant Exercise

Toronto, Ontario – June 6, 2017 – U3O8 Corp. (TSX: UWE), (OTCQB: UWEFF) (“U3O8 Corp.” or the “Company”) is pleased to announce that, as part of the capital restructuring spearheaded by the proposed share consolidation to be voted upon at the Annual and Special Meeting to be held on June 22, 2017, it has reached agreement with a shareholder to reprice and accelerate an aggregate total of 19.3 million previously issued common share purchase warrants (the “Warrants’). In addition, Dr. Keith Barron, founder and director of U3O8 Corp., has offered to exercise out-of-the-money warrants as a means of providing the Company with working capital that is not dilutive to U3O8 Corp. shareholders.